A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis
暂无分享,去创建一个
David Hilton-Jones | Janice L Holton | Caroline Sewry | Michael Hanna | J. Holton | M. Hanna | W. Squier | C. Sewry | D. Hilton‐Jones | Stefen Brady | Waney Squier | S. Brady
[1] K. Moons,et al. Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis , 2001, Neuromuscular Disorders.
[2] David Hilton-Jones,et al. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[3] David Hilton-Jones,et al. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009 , 2010, Neuromuscular Disorders.
[4] David Hilton-Jones,et al. Long-term observational study of sporadic inclusion body myositis. , 2011, Brain : a journal of neurology.
[5] S. Marie,et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. , 2007, Arthritis and rheumatism.
[6] I. Ferrer,et al. Molecular pathology of myofibrillar myopathies , 2008, Expert Reviews in Molecular Medicine.
[7] Andrew G. Engel,et al. αB-Crystallin immunolocalization yields new insights into inclusion body myositis , 2000, Neurology.
[8] G. Gronseth,et al. Inclusion body myositis: Clinical and pathological boundaries , 1996, Annals of neurology.
[9] Margaret M. Esiri,et al. Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not β-amyloid , 1995, Neuroscience Letters.
[10] Shin J. Oh,et al. Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers , 1993, Brain Research.
[11] Frank L Mastaglia,et al. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches , 2007, The Lancet Neurology.
[12] A. Hiniker,et al. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies , 2013, Acta neuropathologica communications.
[13] Steven A Greenberg,et al. Theories of the Pathogenesis of Inclusion Body Myositis , 2010, Current rheumatology reports.
[14] Timothy Day,et al. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis , 2008, Journal of Clinical Neuroscience.
[15] W. Engel,et al. In sporadic inclusion body myositis muscle fibres TDP‐43‐positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments , 2011, Neuropathology and applied neurobiology.
[16] R. Gherardi,et al. Inclusion body myositis in French patients. A clinicopathological evaluation , 1990, Neuropathology and applied neurobiology.
[17] Andrew G Engel,et al. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM , 2008, Neurology.
[18] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.
[19] F L Mastaglia,et al. Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[20] A. Pestronk,et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[21] I. Nonaka,et al. Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies , 2012, PloS one.
[22] M. Dalakas,et al. Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.
[23] V. Askanas,et al. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis , 2009, Acta Neuropathologica.
[24] T. Maisonobe,et al. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[25] Steven A Greenberg,et al. How citation distortions create unfounded authority: analysis of a citation network , 2009, BMJ : British Medical Journal.